These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1541770)

  • 1. Seasonal variations of the dexamethasone suppression test in depression compared with schizophrenia: a gender effect.
    Rybakowski J; Plocka M
    J Affect Disord; 1992 Feb; 24(2):87-91. PubMed ID: 1541770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dexamethasone suppression test in endogenous depression and schizophrenia in male and female patients].
    Płocka M; Matkowski K; Lehmann W; Kanarkowski R; Rybakowski J
    Psychiatr Pol; 1992; 26(5):373-80. PubMed ID: 1302336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression, negative and positive symptoms, and the DST in schizophrenia.
    Minas IH; Jackson HJ; Joshua SD; Burgess PM
    Schizophr Res; 1990; 3(5-6):321-7. PubMed ID: 2282337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone suppression test: use of two different dexamethasone doses.
    Hwang S; Zander J; Garvey M
    J Clin Psychiatry; 1984 Sep; 45(9):390-2. PubMed ID: 6469924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of diagnosis and age on the DST: a metaanalytic approach.
    Sharma RP; Pandey GN; Janicak PG; Peterson J; Comaty JE; Davis JM
    Biol Psychiatry; 1988 Sep; 24(5):555-68. PubMed ID: 3167144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression dexamethasone nonsuppression and negative symptoms in schizophrenia.
    Addington D; Addington J
    Can J Psychiatry; 1990 Jun; 35(5):430-3. PubMed ID: 2372754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative symptoms of schizophrenia and the dexamethasone suppression test.
    Garyfallos G; Lavrentiadis G; Amoutzias D; Monas K; Manos N
    Acta Psychiatr Scand; 1993 Dec; 88(6):425-8. PubMed ID: 8310850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seasonal variation in the dexamethasone suppression test: a longitudinal study in chronic schizophrenics and in healthy subjects.
    Monteleone P; Piccolo A; Martino M; Maj M
    Neuropsychobiology; 1994; 30(2-3):61-5. PubMed ID: 7800165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple HPA profiles in endogenous depression: effect of age and sex on cortisol and beta-endorphin.
    Akil H; Haskett RF; Young EA; Grunhaus L; Kotun J; Weinberg V; Greden J; Watson SJ
    Biol Psychiatry; 1993 Jan; 33(2):73-85. PubMed ID: 8382535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dexamethasone suppression test in residual schizophrenia with depression.
    Munro JG; Hardiker TM; Leonard DP
    Am J Psychiatry; 1984 Feb; 141(2):250-2. PubMed ID: 6691488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence of abnormal dexamethasone suppression in schizophrenia: a review and a meta-analytic comparison with the incidence in normal controls.
    Yeragani VK
    Can J Psychiatry; 1990 Mar; 35(2):128-32. PubMed ID: 2138504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone suppression test and noradrenergic function in affective and schizophrenic disorders.
    Sora I; Nishimon K; Otsuki S
    Biol Psychiatry; 1986 Jun; 21(7):621-31. PubMed ID: 3708036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dexamethasone suppression test in schizophrenia.
    Sawyer J; Jeffries JJ
    J Clin Psychiatry; 1984 Sep; 45(9):399-402. PubMed ID: 6469927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.
    Stokes PE; Stoll PM; Koslow SH; Maas JW; Davis JM; Swann AC; Robins E
    Arch Gen Psychiatry; 1984 Mar; 41(3):257-67. PubMed ID: 6367690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortisol suppression per nanogram per milliliter of plasma dexamethasone in depressive and normal subjects.
    Carson SW; Halbreich U; Yeh CM; Asnis G; Goldstein S
    Biol Psychiatry; 1988 Sep; 24(5):569-77. PubMed ID: 3167145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dexamethasone suppression test in dementia: a review of the literature.
    Skare S; Pew B; Dysken M
    J Geriatr Psychiatry Neurol; 1990; 3(3):124-38. PubMed ID: 2282129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone suppression test and depressive symptoms in schizophrenics and endogenous depressed patients.
    Perényi A; Frecska E; Rihmer Z; Arató M
    Pharmacopsychiatry; 1987 Mar; 20(2):48-50. PubMed ID: 3588661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 2-mg dexamethasone suppression test in differentiating major depression with psychosis from schizophrenia.
    Clower CG
    J Clin Psychopharmacol; 1986 Dec; 6(6):363-5. PubMed ID: 3805330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dexamethasone suppression test in patients with mood disorders.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Parker CR; Weissenburger JE; Crowley GT; Khatami M; Vasavada N
    J Clin Psychiatry; 1996 Oct; 57(10):470-84. PubMed ID: 8909334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seasonal variation and the results of the dexamethasone suppression test.
    Harris B; Watkins S; Newcombe R; Cook N; Read G; Riad-Fahmy D
    J Affect Disord; 1990 Oct; 20(2):115-20. PubMed ID: 2148325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.